HLA Antigens and Post Renal Transplant Lymphoproliferative Disease: HLA-B Matching Is Critical-Reference-Cited by-同舟云学术

HLA Antigens and Post Renal Transplant Lymphoproliferative Disease: HLA-B Matching Is Critical

Published:2005-09-15 Issue:5 Volume:80 Page:595-599
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Bakker Nicolaas A.,van Imhoff Gustaaf W.,Verschuuren Erik A.M.,van Son Willem J.,van der Heide Jaap J. Homan,Lems Simon P.M.,Veeger Nic J.G.M.,Kluin Philip M.,Kluin-Nelemans Hanneke C.,Hepkema Bouke G.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference20 articles.

1. The Epstein-Barr virus and post-transplant lymphoproliferative disease: interplay of immunosuppression, EBV, and the immune system in disease pathogenesis.;Tanner;Transpl Infect Dis,2001

2. Pretransplantation assessment of the risk of lymphoproliferative disorder.;Walker;Clin Infect Dis,1995

3. Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients.;Swinnen;N Engl J Med,1990

4. Immunosuppression and the risk of post-transplant malignancy among cadaveric first kidney transplant recipients.;Bustami;Am J Transplant,2004

5. Lymphomas after solid organ transplantation: a collaborative transplant study report.;Opelz;Am J Transplant,2004

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanistic Understanding of EBV+Lymphoproliferative Disease Development After Transplantation;Transplantation;2024-02-05

2. Role of standard HLA mismatch in modifying associations between non-pharmacologic risk factors and solid organ malignancy after kidney transplantation;Transplant Immunology;2023-10

3. Malignancy Following Lung Transplantation;Encyclopedia of Respiratory Medicine;2022

4. Epidemiology of PTLD After SOT;Post-Transplant Lymphoproliferative Disorders;2021

5. HLA and lung transplantation;Frontiers of Medicine;2019-06